1. Pink Sheet

US FDA Still Not Scheduling In-Person Meetings Despite Sponsor Requests

 
• By Derrick Gingery

Some sponsors appear to be growing antsy to meet with agency staff and advisory committees in-person, but CDER continues to schedule only virtual meetings.

FDA not having in-person meetings
Some stakeholders are growing inpatient for the FDA to resume in-person meetings. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

Sponsors are beginning to wonder why the US Food and Drug Administration’s Center for Drug Evaluation and Research still will not allow in-person meetings at its White Oak headquarters, especially as they and others in industry return to work in their offices.

The agency’s Office of Operations has been able to support in-person events for several months

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA Performance Tracker

More from Regulatory Trackers